Initiating buprenorphine treatment for opioid use disorder during short-term in-patient ‘detoxification’: a randomized clinical trial

Lignende værker

• OPEN-LABEL TRIAL OF AN INJECTION DEPOT FORMULATION OF BUPRENORPHINE IN OPIOID DETOXIFICATION
  af: SOBEL, B.X
• PREDICTORS OF DISCHARGES AGAINST MEDICAL ADVICE FROM A SHORT-TERM HOSPITAL DETOXIFICATION UNIT
  af: ARMENIAN, S.H
• A MULTI-CENTER RANDOMIZED TRIAL OF BUPRENORPHINE-NALOXONE VERSUS CLONIDINE FOR OPIOID DETOXIFICATION: FINDINGS FROM THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK
  af: LING, W.
• OPIOID DETOXIFICATION USING HIGH DOSES OF BUPRENORPHINE IN 24 HOURS: A RANDOMIZED, DOUBLE BLIND, CONTROLLED CLINICAL TRIAL
  af: ASSADI, S.M
• PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
  af: ZIEDONIS, D.M